Strategies directed to promote inhibition of PDE activity have been applied as therapeutic tools in a variety of lung and inflammatory disorders, such as asthma and chronic obstructive pulmonary disease (COPD) but also in neuronal, cardiovascular, and other conditions (Table 1). The gene discussed is ALDH7A1; the disease is chronic obstructive pulmonary disease.